Sandoz Moves Ahead With High-Concentration Adalimumab In Europe

Approval For Humira Rival’s 100mg/ml Formulation Follows FDA Nod Last Month

 
• By Dave Wallace
  
Europe from space sunrise new dawn
Sandoz has a European approval for high-concentration adalimumab • Source: Deco / Alamy Stock Photo

More from Biosimilars

More from Products